These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 23721963)

  • 1. Use of the light/dark test for anxiety in adult and adolescent male rats.
    Arrant AE; Schramm-Sapyta NL; Kuhn CM
    Behav Brain Res; 2013 Nov; 256():119-27. PubMed ID: 23721963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of the elevated T-maze to study anxiety in mice.
    Carvalho-Netto EF; Nunes-de-Souza RL
    Behav Brain Res; 2004 Jan; 148(1-2):119-32. PubMed ID: 14684253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for noradrenergic involvement in mediating the FG 7142 discriminative stimulus.
    Leidenheimer NJ; Schechter MD
    Pharmacol Biochem Behav; 1992 Sep; 43(1):77-83. PubMed ID: 1357678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The anxiogenic beta-carboline FG-7142 inhibits locomotor exploration similarly in postweanling and adult rats.
    Jaskiw GE; Lipska BK; Weinberger DR
    Neurosci Lett; 2003 Jul; 346(1-2):5-8. PubMed ID: 12850534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FG7142, yohimbine, and βCCE produce anxiogenic-like effects in the elevated plus-maze but do not affect brainstem activated hippocampal theta.
    Yeung M; Lu L; Hughes AM; Treit D; Dickson CT
    Neuropharmacology; 2013 Dec; 75():47-52. PubMed ID: 23851259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A two-compartment exploratory model to study anxiolytic/anxiogenic effects of drugs in the rat.
    Merlo Pich E; Samanin R
    Pharmacol Res; 1989; 21(5):595-602. PubMed ID: 2574443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of subchronic phencyclidine on anxiety in the light-enhanced startle-, light/dark exploration- and open field tests.
    Enkel T; Thomas M; Bartsch D
    Behav Brain Res; 2013 Apr; 243():61-5. PubMed ID: 23299039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serotonergic systems associated with arousal and vigilance behaviors following administration of anxiogenic drugs.
    Abrams JK; Johnson PL; Hay-Schmidt A; Mikkelsen JD; Shekhar A; Lowry CA
    Neuroscience; 2005; 133(4):983-97. PubMed ID: 15916857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ethopharmacological evaluation of the rat exposure test: a prey-predator interaction test.
    Campos KF; Amaral VC; Rico JL; Miguel TT; Nunes-de-Souza RL
    Behav Brain Res; 2013 Mar; 240():160-70. PubMed ID: 23195112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of phencyclidine (PCP) on anxiety-like behavior in the elevated plus maze and the light-dark exploration test are age dependent, sexually dimorphic, and task dependent.
    Turgeon SM; Kim D; Pritchard M; Salgado S; Thaler A
    Pharmacol Biochem Behav; 2011 Nov; 100(1):191-8. PubMed ID: 21889525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nociceptin/orphanin FQ increases anxiety-related behavior and circulating levels of corticosterone during neophobic tests of anxiety.
    Fernandez F; Misilmeri MA; Felger JC; Devine DP
    Neuropsychopharmacology; 2004 Jan; 29(1):59-71. PubMed ID: 14532912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The anxiogenic agents, yohimbine and FG 7142, disrupt the noradrenergic response to novelty.
    Mason K; Heal DJ; Stanford SC
    Pharmacol Biochem Behav; 1998 Jun; 60(2):321-7. PubMed ID: 9632213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The modified light/dark transition test in mice: evaluation of classic and putative anxiolytic and anxiogenic drugs.
    Shimada T; Matsumoto K; Osanai M; Matsuda H; Terasawa K; Watanabe H
    Gen Pharmacol; 1995 Jan; 26(1):205-10. PubMed ID: 7713361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of photoperiod and sex on locomotor behavior of meadow voles (Microtus pennsylvanicus) in an automated light-dark 'anxiety' test.
    Ossenkopp KP; van Anders SM; Engeland CG; Kavaliers M
    Psychoneuroendocrinology; 2005 Oct; 30(9):869-79. PubMed ID: 15979243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex differences in open-field behavior in response to the beta-carboline FG 7142 in rats.
    Meng ID; Drugan RC
    Physiol Behav; 1993 Oct; 54(4):701-5. PubMed ID: 8248346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-Hydroxytryptamine2C receptor contribution to m-chlorophenylpiperazine and N-methyl-beta-carboline-3-carboxamide-induced anxiety-like behavior and limbic brain activation.
    Hackler EA; Turner GH; Gresch PJ; Sengupta S; Deutch AY; Avison MJ; Gore JC; Sanders-Bush E
    J Pharmacol Exp Ther; 2007 Mar; 320(3):1023-9. PubMed ID: 17138863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sodium phenobarbitone reverses the anxiogenic effects of compounds acting at three different central sites.
    Johnston AL; File SE
    Neuropharmacology; 1989 Jan; 28(1):83-8. PubMed ID: 2538770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PLDT (planarian light/dark test): an invertebrate assay to quantify defensive responding and study anxiety-like effects.
    Zewde AM; Yu F; Nayak S; Tallarida C; Reitz AB; Kirby LG; Rawls SM
    J Neurosci Methods; 2018 Jan; 293():284-288. PubMed ID: 29042260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Social approach-avoidance behavior of a high-anxiety strain of rats: effects of benzodiazepine receptor ligands.
    Nicolas LB; Prinssen EP
    Psychopharmacology (Berl); 2006 Jan; 184(1):65-74. PubMed ID: 16328377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of an anxiety-related phenotype in galanin overexpressing transgenic mice.
    Holmes A; Yang RJ; Crawley JN
    J Mol Neurosci; 2002; 18(1-2):151-65. PubMed ID: 11931346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.